LEADER 01037nam1-2200373---450- 001 990000778980203316 035 $a0077898 035 $aUSA010077898 035 $a(ALEPH)000077898USA01 035 $a0077898 100 $a20011129d--------km-y0itay0103----ba 101 $afre 102 $aFR 105 $a||||||||001yy 200 1 $aCours de droit civil$fPhilippe Malaurie, Laurent Aynés 210 $aParis$cEditions Cujas 215 $av$d24 cm 410 $12001 606 0 $aDiritto civile 676 $a346.44 700 1$aMALAURIE,$bPhilippe$0228045 701 1$aAYNÉS,$bLaurent$0419843 801 0$aIT$bsalbc$gISBD 912 $a990000778980203316 951 $aIG XXI 340$bE.C.$cIG XXI 959 $aBK 969 $aECO 979 $aPATTY$b90$c20011129$lUSA01$h1051 979 $aPATTY$b90$c20011129$lUSA01$h1103 979 $aPATTY$b90$c20020326$lUSA01$h1730 979 $c20020403$lUSA01$h1725 979 $aPATRY$b90$c20040406$lUSA01$h1654 996 $aCours de droit civil$9666827 997 $aUNISA LEADER 04101nam 2200541 450 001 9910483453403321 005 20220711174156.0 010 $a3-030-52021-8 024 7 $a10.1007/978-3-030-52021-2 035 $a(CKB)4100000011476682 035 $a(MiAaPQ)EBC6360788 035 $a(DE-He213)978-3-030-52021-2 035 $a(PPN)250223090 035 $a(EXLCZ)994100000011476682 100 $a20210226d2021 uy 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aChemotherapy and immunotherapy in urologic oncology $ea guide for the advanced practice provider /$fedited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi 205 $a1st ed. 2021. 210 1$aCham, Switzerland :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (XIV, 307 p. 22 illus., 19 illus. in color.) 311 $a3-030-52020-X 320 $aIncludes bibliographical references and index. 327 $aIntroduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer. 330 $aThis book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book?s chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. . 606 $aUrologic Neoplasms$xTreatment 606 $aUrinary organs$xCancer$xTreatment 606 $aUrologic Neoplasms$xtherapy 606 $aUrinary Tract 615 0$aUrologic Neoplasms$xTreatment. 615 0$aUrinary organs$xCancer$xTreatment. 615 2$aUrologic Neoplasms$xtherapy. 615 2$aUrinary Tract. 676 $a616.9946 702 $aLizardi-Calvaresi$b Anne E. 702 $aTrabulsi$b Edouard J. 702 $aLallas$b Costas D. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910483453403321 996 $aChemotherapy and immunotherapy in urologic oncology$92851271 997 $aUNINA